C07K 14/463
From amphibians
Official title: {from amphibians}
C07K14/463 (From amphibians) appears on 132 US grants and 175 published applications in this corpus.
Search patents in C07K- Granted patents
- 132
- Published applications
- 175
- Assignees
- 120
- Inventors
- 345
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 7 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 5 | 0 |
| 2002 | 8 | 6 |
| 2003 | 7 | 8 |
| 2004 | 3 | 8 |
| 2005 | 2 | 2 |
| 2006 | 3 | 3 |
| 2007 | 3 | 3 |
| 2008 | 5 | 8 |
| 2009 | 0 | 5 |
| 2010 | 2 | 3 |
| 2011 | 4 | 5 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 1 | 6 |
| 2015 | 5 | 11 |
| 2016 | 5 | 17 |
| 2017 | 6 | 13 |
| 2018 | 9 | 5 |
| 2019 | 7 | 10 |
| 2020 | 6 | 11 |
| 2021 | 5 | 7 |
| 2022 | 5 | 10 |
| 2023 | 1 | 8 |
| 2024 | 5 | 11 |
| 2025 | 6 | 4 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically modified microorganisms that carry out the heterologous production of modified versions of the surfactant protein LV-ranaspumin-1(LV-RSN-1), the modified versions of said surfactant protein, the synthetic genes encoding said surfactant protein, the expression cassettes containing said synthetic genes, and the expression vectors containing said synthetic genes21 Apr 2026US 12,606,601 B2Petroleo Brasileiro S.A. - Petrobras
- Antimicrobial peptides with alpha-core helices31 Mar 2026US 12,590,131 B2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Use of esculentin and its derivatives for use in the treatment of cystic fibrosis24 Mar 2026US 12,583,893 B2Fondazione Per La Ricerca Sulla Fibrosi Cistica
- Compositions, methods, and applications of a synthetic surfactant16 Dec 2025US 12,495,796 B21283581 Bc Ltd
- Activatable therapeutic peptides and uses thereof21 Oct 2025US 12,448,418 B2Massachusetts Institute of Technology
- Compositions, methods, and applications of a synthetic surfactant1 Oct 2026US 2026/0293886 A1
- Antimicrobial peptides with alpha-core helices24 Sep 2026US 2026/0285927 A1Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Fibroblast Activation Protein Alpha-Cleavable Pro-Peptides and Methods of Use30 Apr 2026US 2026/0115332 A1The Regents of the University of California
- Pharmaceutical compositions and methods of treating psp5 Feb 2026US 2026/0034194 A1The Board of Trustees of the Leland Stanford Junior University
- Novel peptide for treating an infectious disease or condition4 Dec 2025US 2025/0368700 A1Omnix Medical Ltd.
Most cited
By later US patents
- Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells200US 6,653,104 B2Immunomedics, Inc. · 2003
- Immunotoxins directed against malignant cells103US 6,395,276 B1Immunomedics, Inc. · 2002
- Use of cationic lipids to deliver CAS997US 9,737,604 B2President and Fellows of Harvard College · 2017
- Delivery system for functional nucleases96US 9,526,784 B2President and Fellows of Harvard College · 2016
- Delivery system for functional nucleases79US 10,682,410 B2President and Fellows of Harvard College · 2020